Fresenius Medical Care AG & Co. KGaA ADR logo

Fresenius Medical Care AG & Co. KGaA ADR (FMS)

Market Closed
3 Jul, 20:00
NYSE NYSE
$
28. 12
-0.2
-0.71%
$
16.5B Market Cap
20.41 P/E Ratio
4.87% Div Yield
119,500 Volume
0 Eps
$ 28.32
Previous Close
Day Range
28.06 28.21
Year Range
17.93 30.46
Want to track FMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 30 days

Summary

FMS closed Thursday lower at $28.12, a decrease of 0.71% from Wednesday's close, completing a monthly decrease of -2.06% or $0.59. Over the past 12 months, FMS stock gained 25.65%.
FMS pays dividends to its shareholders, with the most recent payment made on Jun 06, 2025. The next estimated payment will be in In 11 months on Jun 06, 2026 for a total of $0.7871.
The last earnings report, released on May 05, 2025, exceeded the consensus estimates by 0.04%. On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports. The next scheduled earnings report is due on Aug 05, 2025.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

FMS Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
FMS vs. RXST: Which Stock Is the Better Value Option?

FMS vs. RXST: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or RxSight, Inc. (RXST). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 2 days ago
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

High-Volume Hemodiafiltration is used for the first time in seven out of 10 CCINSHAE centers in Mexico In Mexico, 240 CCINSHAE patients are now being treated; more than 410 regular patients also treated Fresenius Medical Care is committed to expanding HighVolumeHDF therapy to all markets where it is not already present, including the United States BAD HOMBURG, Germany , July 3, 2025 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, will extend High-Volume Hemodiafiltration (HighVolumeHDF) access for patients in seven out of 10 centers in Mexico, by partnering with the country's Coordination of National Institutes of Health and Specialty Hospitals (CCINSHAE) to develop a pilot program that provides low-income patients without medical coverage in Mexico with access to hemodialysis therapies.   Fresenius Medical Care Mexico and CCINSHAE signed a two-year contract to enable the installation of the Fresenius Medical Care 5008S CorDiax technology in participating renal treatment centers in CCINCSHAE Centers in Mexico City (CDMX) and its metropolitan area, for a total of 150 systems in all.

Prnewswire | 3 days ago
FMS Stock Likely to Gain on New Optimization Plan FME Reignite

FMS Stock Likely to Gain on New Optimization Plan FME Reignite

Fresenius Medical Care unveils FME Reignite, targeting one billion euros in cost savings, tech upgrades and enhanced shareholder returns.

Zacks | 1 week ago

Fresenius Medical Care AG & Co. KGaA ADR Dividends

Fresenius Medical Care AG & Co. KGaA ADR logo
FMS In 10 months
Estimated
Annual
$0.79 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 1 month ago
Paid
Annual
$0.79 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 17 May 2024
Paid
Annual
$0.63 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 17 May 2023
Paid
Annual
$0.62 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 13 May 2022
Paid
Annual
$0.71 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 24 May 2021
Paid
Annual
$0.83 Per Share

Fresenius Medical Care AG & Co. KGaA ADR Earnings

5 Aug 2025 (In 1 month) Date
0.49
Cons. EPS
-
EPS
5 May 2025 Date
0.38
Cons. EPS
0.42
EPS
25 Feb 2025 Date
0.4
Cons. EPS
0.46
EPS
5 Nov 2024 Date
0.38
Cons. EPS
0.4
EPS
30 Jul 2024 Date
0.34
Cons. EPS
0.24
EPS
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS In 10 months
Estimated
Annual
$0.79 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 1 month ago
Paid
Annual
$0.79 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 17 May 2024
Paid
Annual
$0.63 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 17 May 2023
Paid
Annual
$0.62 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 13 May 2022
Paid
Annual
$0.71 Per Share
Fresenius Medical Care AG & Co. KGaA ADR logo
FMS 24 May 2021
Paid
Annual
$0.83 Per Share
5 Aug 2025 (In 1 month) Date
0.49
Cons. EPS
-
EPS
5 May 2025 Date
0.38
Cons. EPS
0.42
EPS
25 Feb 2025 Date
0.4
Cons. EPS
0.46
EPS
5 Nov 2024 Date
0.38
Cons. EPS
0.4
EPS
30 Jul 2024 Date
0.34
Cons. EPS
0.24
EPS

Fresenius Medical Care AG & Co. KGaA ADR (FMS) FAQ

What is the stock price today?

The current price is $28.12.

On which exchange is it traded?

Fresenius Medical Care AG & Co. KGaA ADR is listed on NYSE.

What is its stock symbol?

The ticker symbol is FMS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4.87%.

What is its market cap?

As of today, the market cap is 16.5B.

What is the earnings per share?

The EPS is 0.49.

When is the next earnings date?

The next earnings report will release on Aug 05, 2025.

Has Fresenius Medical Care AG & Co. KGaA ADR ever had a stock split?

No, there has never been a stock split.

Fresenius Medical Care AG & Co. KGaA ADR Profile

Medical - Care Facilities Industry
Healthcare Sector
Helen Giza CEO
NYSE Exchange
358029106 Cusip
DE Country
112,035 Employees
23 May 2025 Last Dividend
4 Dec 2012 Last Split
- IPO Date

Overview

Fresenius Medical Care AG is a leading global provider in the field of dialysis and related services, catered towards individuals suffering from renal diseases. Established in 1996 and headquartered in Bad Homburg, Germany, the company has a broad reach extending across Germany, North America, and other international locations. Fresenius Medical Care AG specializes in delivering dialysis treatment and associated laboratory and diagnostic services mainly through its extensive network of outpatient dialysis clinics. Additionally, the company holds contracts with hospitals in the United States to offer dialysis services to hospitalized end-stage renal disease (ESRD) patients and those facing acute kidney failure. Beyond its core services, Fresenius Medical Care AG is engaged in the development, manufacture, and distribution of a wide range of health care products, as well as in the development and licensing of renal pharmaceuticals. It serves a diverse clientele, including dialysis clinics, hospitals, and specialized treatment facilities, through direct sales and a blend of local sales forces, independent distributors, dealers, and sales agents.

Products and Services

Fresenius Medical Care AG provides a comprehensive suite of products and services tailored to meet the needs of renal disease patients and health care providers:

  • Dialysis Services and Support: The company delivers dialysis treatment alongside laboratory and diagnostic services through its outpatient clinics. It also provides training, clinical monitoring, follow-up assistance, and home delivery of supplies for patients, alongside contracted dialysis services for hospitalized patients.
  • Health Care Products: The product line includes items such as polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, solutions, and granulates. These are essential for performing dialysis treatment both in clinics and at home.
  • Renal Pharmaceuticals: Fresenius Medical Care AG works on the development, acquisition, and in-licensing of renal pharmaceuticals. The company also supplies renal medications directly to patients' homes or dialysis clinics, ensuring that those undergoing treatment have easy access to their necessary medications.
  • Water Treatment Systems and Other Supplies: The comprehensive list of supplies includes bloodlines, hemodialysis concentrates, peritoneal dialysis solutions, and systems for water treatment, which ensure the safe conduct of dialysis treatment by managing the cleanliness and purity of water used.
  • Cardiopulmonary and Apheresis Products: Beyond renal care, the company also offers products for acute cardiopulmonary support and apheresis procedures, addressing the needs of patients with cardiovascular issues or those requiring blood purification.
  • Specialized Medical Services: Fresenius Medical Care AG provides additional specialized services, such as vascular, cardiovascular, and endovascular specialty services, ambulatory surgery center management for vascular care, and professional services for nephrology and cardiology. These are intended to complement the core dialysis services by addressing the broader health needs of renal disease patients.

Contact Information

Address: Else-KrOener Strasse 1
Phone: 49 6172 608 2522